Skip to main content

Table 2 Fatty acid profiles of the study oils [% FAME]. Combined GC-FID and silver-ion HPLC analysisa

From: Effects of a dietary intervention with conjugated linoleic acid on immunological and metabolic parameters in children and adolescents with allergic asthma – a placebo-controlled pilot trial

Fatty acid (common name)

CLA

Placebo oil

C14:0 (myristic acid)

0

0.1

C16:0 (palmitic acid)

0.1

8.2

C18:0 (stearic acid)

0.5

3.4

C18:1c9 (oleic acid)

1.8

19.9

C18:1c11 (vaccenic acid)

0.3

0

C18:2n-6 (linoleic acid)

3.1

64.5

C18:3n-3 (alpha-linolenic acid)

0.2

1.0

C20:0 (arachidic acid)

0.1

0.5

C20:1 (eicosenoic acid)

0.5

0.3

C20:5n-3 (eicosapentaenoic acid)

0

0

Other

6.8

2.3

∑ CLA

86.6

0

c9,t11b

66.1

 

c9,c11

19.2

 

t9,t11c

0.9

 

t10,c12

0.1

 
  1. aFor detailed information, please refer to [11]
  2. bCorrected for co-eluting t8,c10
  3. cCorrected for co-eluting t8,t10